Munafa Stock Market Course + Intraday & FNO calls 
GlaxosmithklinePharmaceuticals GLAXO full analysis,charts,indicators,moving averages,SMA,DMA,EMA,ADX,MACD,RSI
Glaxosmithkline Pharmaceuticals GLAXO WideScreen charts, DMA,SMA,EMA technical analysis, forecast prediction, by indicators ADX,MACD,RSI,CCI NSE stock exchange
operates under Pharmaceuticals sector
- IntraDay predictions, targets, What to do GLAXO
- Forcast & Targets GLAXO
- GLAXO Experts view
- Tomorrow's Movement GLAXO
- Technical Analysis Reports
- All in One Charts
- All indicators in One Charts
- GLAXO History
- Money flow charts
- Weekly charts
- Monthly charts
- Moving averages charts
- MACD charts
- Force Index charts
- Stochastics charts
- PVM charts
- RSI and MRSI charts
- Renko charts
- Point and Figure charts
Daily price and charts and targets GlaxosmithklinePharmaceuticals
Strong intraday Stock price targets for GlaxosmithklinePharmaceuticals are 2945.25 and 3087.55
| Intraday Target 1 | 2846.2 |
| Intraday Target 2 | 2902 |
| Intraday Target 3 | 2988.5 |
| Intraday Target 4 | 3044.3 |
| Intraday Target 5 | 3130.8 |
Daily price and volume Glaxosmithkline Pharmaceuticals
| Date | Closing | Open | Range | Volume | Mon 07 September 2026 | 2957.80 (-0.01%) | 2937.90 | 2932.70 - 3075.00 | 1.2302 times | Fri 04 September 2026 | 2958.10 (0.7%) | 2938.90 | 2925.50 - 2972.80 | 0.3802 times | Thu 03 September 2026 | 2937.50 (-0.42%) | 2962.40 | 2930.40 - 2998.00 | 0.4427 times | Wed 02 September 2026 | 2949.90 (-1.54%) | 2972.60 | 2908.50 - 2990.10 | 0.4681 times | Tue 01 September 2026 | 2996.10 (-1.77%) | 3040.00 | 2966.40 - 3040.10 | 0.7102 times | Mon 31 August 2026 | 3050.10 (-1.81%) | 3106.50 | 3035.20 - 3120.00 | 1.6257 times | Fri 28 August 2026 | 3106.40 (1.22%) | 3069.00 | 3052.70 - 3120.70 | 1.0731 times | Thu 27 August 2026 | 3069.10 (1.14%) | 3030.00 | 3018.90 - 3118.00 | 1.8131 times | Wed 26 August 2026 | 3034.40 (2.4%) | 2995.00 | 2975.20 - 3049.90 | 0.8779 times | Tue 25 August 2026 | 2963.40 (1.08%) | 2953.80 | 2917.60 - 3010.00 | 1.3786 times | Mon 24 August 2026 | 2931.70 (1.02%) | 2875.10 | 2865.40 - 2955.90 | 0.6334 times |
Weekly price and charts GlaxosmithklinePharmaceuticals
Strong weekly Stock price targets for GlaxosmithklinePharmaceuticals GLAXO are 2945.25 and 3087.55
| Weekly Target 1 | 2846.2 |
| Weekly Target 2 | 2902 |
| Weekly Target 3 | 2988.5 |
| Weekly Target 4 | 3044.3 |
| Weekly Target 5 | 3130.8 |
Weekly price and volumes for Glaxosmithkline Pharmaceuticals
| Date | Closing | Open | Range | Volume | Mon 07 September 2026 | 2957.80 (-0.01%) | 2937.90 | 2932.70 - 3075.00 | 0.2725 times | Fri 04 September 2026 | 2958.10 (-4.77%) | 3106.50 | 2908.50 - 3120.00 | 0.8034 times | Fri 28 August 2026 | 3106.40 (7.04%) | 2875.10 | 2865.40 - 3120.70 | 1.2794 times | Fri 21 August 2026 | 2902.20 (7.94%) | 2688.00 | 2660.00 - 3054.90 | 4.0745 times | Fri 14 August 2026 | 2688.80 (3.43%) | 2595.80 | 2576.10 - 2697.00 | 0.4943 times | Fri 07 August 2026 | 2599.70 (-2.1%) | 2665.40 | 2515.00 - 2684.00 | 0.5527 times | Fri 31 July 2026 | 2655.40 (5.61%) | 2524.00 | 2494.10 - 2679.00 | 0.7283 times | Fri 24 July 2026 | 2514.30 (2.42%) | 2454.50 | 2445.40 - 2570.00 | 0.5694 times | Fri 17 July 2026 | 2454.80 (0.68%) | 2439.90 | 2406.30 - 2527.00 | 0.7173 times | Fri 10 July 2026 | 2438.20 (1.78%) | 2390.20 | 2370.00 - 2460.80 | 0.5084 times | Fri 03 July 2026 | 2395.50 (1.73%) | 2347.80 | 2335.40 - 2504.70 | 1.1099 times |
Monthly price and charts GlaxosmithklinePharmaceuticals
Strong monthly Stock price targets for GlaxosmithklinePharmaceuticals GLAXO are 2849.9 and 3016.4
| Monthly Target 1 | 2813.93 |
| Monthly Target 2 | 2885.87 |
| Monthly Target 3 | 2980.4333333333 |
| Monthly Target 4 | 3052.37 |
| Monthly Target 5 | 3146.93 |
Monthly price and volumes Glaxosmithkline Pharmaceuticals
| Date | Closing | Open | Range | Volume | Mon 07 September 2026 | 2957.80 (-3.03%) | 3040.00 | 2908.50 - 3075.00 | 0.2198 times | Mon 31 August 2026 | 3050.10 (14.86%) | 2665.40 | 2515.00 - 3120.70 | 2.0762 times | Fri 31 July 2026 | 2655.40 (8.37%) | 2476.80 | 2370.00 - 2679.00 | 0.9115 times | Tue 30 June 2026 | 2450.30 (10.86%) | 2200.00 | 2088.10 - 2460.90 | 1.6383 times | Fri 29 May 2026 | 2210.20 (-5.4%) | 2342.00 | 2194.40 - 2520.00 | 1.1351 times | Thu 30 April 2026 | 2336.40 (2.34%) | 2305.00 | 2261.90 - 2529.90 | 0.6992 times | Mon 30 March 2026 | 2283.00 (-11.22%) | 2520.00 | 2217.60 - 2581.60 | 0.5634 times | Fri 27 February 2026 | 2571.60 (7.08%) | 2421.40 | 2342.10 - 2719.80 | 0.8221 times | Fri 30 January 2026 | 2401.60 (-2.91%) | 2476.00 | 2220.30 - 2528.00 | 0.7343 times | Wed 31 December 2025 | 2473.60 (-3.73%) | 2551.00 | 2362.60 - 2635.00 | 1.2001 times | Fri 28 November 2025 | 2569.50 (-1.88%) | 2644.00 | 2404.20 - 2694.00 | 1.001 times |
Yearly price and charts GlaxosmithklinePharmaceuticals
Strong yearly Stock price targets for GlaxosmithklinePharmaceuticals GLAXO are 2522.95 and 3555.55
| Yearly Target 1 | 1689.6 |
| Yearly Target 2 | 2323.7 |
| Yearly Target 3 | 2722.2 |
| Yearly Target 4 | 3356.3 |
| Yearly Target 5 | 3754.8 |
Yearly price and volumes Glaxosmithkline Pharmaceuticals
| Date | Closing | Open | Range | Volume | Mon 07 September 2026 | 2957.80 (19.57%) | 2476.00 | 2088.10 - 3120.70 | 0.8599 times | Wed 31 December 2025 | 2473.60 (9.85%) | 2235.00 | 1921.00 - 3515.70 | 2.48 times | Tue 31 December 2024 | 2251.85 (18.63%) | 1905.90 | 1842.05 - 3088.00 | 2.1084 times | Fri 29 December 2023 | 1898.15 (43.94%) | 1300.00 | 1227.00 - 1959.00 | 1.1721 times | Fri 30 December 2022 | 1318.75 (-24.93%) | 1763.00 | 1295.95 - 1789.90 | 0.6808 times | Fri 31 December 2021 | 1756.65 (8.17%) | 1607.20 | 1376.00 - 1918.75 | 0.9081 times | Thu 31 December 2020 | 1623.95 (0.85%) | 1626.00 | 962.65 - 1807.50 | 1.0134 times | Tue 31 December 2019 | 1610.30 (6.27%) | 1500.35 | 1130.00 - 1737.00 | 0.4335 times | Mon 31 December 2018 | 1515.35 (-39.13%) | 2490.00 | 1251.00 - 3600.00 | 0.2205 times | Fri 29 December 2017 | 2489.30 (-8.81%) | 2725.00 | 2201.20 - 2798.50 | 0.1233 times | Fri 30 December 2016 | 2729.80 (-17.15%) | 3277.00 | 2600.00 - 3872.00 | 0.1236 times |
Indicator Analysis of GlaxosmithklinePharmaceuticals
Tomorrow's movement Prediction of Glaxosmithkline Pharmaceuticals GLAXO appears to be in uptrend. And this trend seems to be continuing further.
Price is above an important level of 2953.28 on charts, and as long as price remains above this level, the uptrend of stock might continue.
Tomorrow's movement Prediction of Glaxosmithkline Pharmaceuticals GLAXO appears to be moving in a flat line. No recent bulk deals happened to affect the stock trend.
Munafa value: 70 as on Mon 07 September 2026
This Munafa value indicates that the stock is moving upwards and might continue to move up.
SMA20 is at 2903 and price is deviating by 154 points
Upper Bollinger band is at 3209 and lower is at 2597, while middle bands are at 2750 and 3056
Price is coming down
Price is above 20day SMA
Price is in lower range of bands
Price action analysis of GlaxosmithklinePharmaceuticals (GLAXO) based on a short term time period is positive, but buyers have become active on the stock recently. This cannot be a definite uptrend, specially if selected time duration is small.
ADX buy sell signal for GlaxosmithklinePharmaceuticals stock for short term is BUY. Signal strength is Strong and stock is gaining momentum.
MACD generated a SELL signal for GlaxosmithklinePharmaceuticals in short term but the sell signal is initial and weak.
GlaxosmithklinePharmaceuticals Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are getting stronger in this stock.
Ichimoku cloud is of green color and prices are above the green cloud Prices appear to be coming down
CCI has generated a buy signal for GlaxosmithklinePharmaceuticals in short term but BUY signal is weak.
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in negative zone. This is the SELL zone
Stock of GlaxosmithklinePharmaceuticals is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 3017.89 and GlaxosmithklinePharmaceuticals GLAXO stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the GlaxosmithklinePharmaceuticals GLAXO stock. Volume based technical analysis of GlaxosmithklinePharmaceuticals GLAXO stock is negative.
GlaxosmithklinePharmaceuticals Stock is giving positive returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
DMA SMA EMA moving averages of Glaxosmithkline Pharmaceuticals GLAXO
DMA (daily moving average) of Glaxosmithkline Pharmaceuticals GLAXO
| DMA period | DMA value |
| 5 day DMA | 2959.88 |
| 12 day DMA | 2988.06 |
| 20 day DMA | 2902.39 |
| 35 day DMA | 2767.2 |
| 50 day DMA | 2669.76 |
| 100 day DMA | 2499.35 |
| 150 day DMA | 2488.4 |
| 200 day DMA | 2483.98 |
EMA (exponential moving average) of Glaxosmithkline Pharmaceuticals GLAXO
| EMA period | EMA current | EMA prev | EMA prev2 |
| 5 day EMA | 2967.33 | 2972.1 | 2979.1 |
| 12 day EMA | 2953.29 | 2952.47 | 2951.45 |
| 20 day EMA | 2898.57 | 2892.34 | 2885.42 |
| 35 day EMA | 2794.22 | 2784.59 | 2774.38 |
| 50 day EMA | 2673.72 | 2662.13 | 2650.05 |
SMA (simple moving average) of Glaxosmithkline Pharmaceuticals GLAXO
| SMA period | SMA current | SMA prev | SMA prev2 |
| 5 day SMA | 2959.88 | 2978.34 | 3008 |
| 12 day SMA | 2988.06 | 2991.55 | 2997.74 |
| 20 day SMA | 2902.39 | 2884.55 | 2866.63 |
| 35 day SMA | 2767.2 | 2753.63 | 2739.25 |
| 50 day SMA | 2669.76 | 2657.69 | 2645.63 |
| 100 day SMA | 2499.35 | 2493.83 | 2488.39 |
| 150 day SMA | 2488.4 | 2484.46 | 2480.96 |
| 200 day SMA | 2483.98 | 2481.66 | 2479.26 |
Fundamentals, profit and EPS of Glaxosmithkline Pharmaceuticals GLAXO
EPS is 61.15 and PE is: 48.37
Last quarter profit: (March 2026 quarter) 277.86 crores (5.70%)
Debt: 33.27 in crores
Market capitalization: 39891.73
EPS is 60.27 and PE is: 49.08
Last quarter profit: (December 2025 quarter) 295.62 crores (22.82%)
Debt: 35.71 in crores
Market capitalization: 38277.29
Videos related to: GlaxosmithklinePharmaceuticals GLAXO full analysis,charts,indicators,moving averages,SMA,DMA,EMA,ADX,MACD,RSI
Hindi Video What Is Needed To Succeed In Stock Markets
- NSE Screeners
- NSE Daily Screener
- NSE Weekly Screener
- NSE Monthly Screener
- Support & Resistance
- NSE Shares Near Support
- NSE Shares Near Resistance
